Squarepoint’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
3C
Squarepoint's ASTH Position: Q2 2026 in Review
Squarepoint sold out of Astrana Health (ASTH) in Q2 2026, closing a stake of 70,168 shares — an estimated $1.72M sold.
Squarepoint first reported a position in ASTH in Q3 2020 and held it in 12 quarters. The position peaked at $2.38M in Q2 2025. 210 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- Squarepoint reported no remaining Astrana Health position as of Q2 2026 after selling out during the quarter.
- Squarepoint sold 70,168 Astrana Health shares in Q2 2026, an estimated $1.72M.
- Squarepoint first reported a position in Astrana Health in Q3 2020 and held it in 12 quarters.
- Squarepoint's Astrana Health position peaked at $2.38M in Q2 2025.
- 210 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.